BioPace develops a hardware-free “biological pacemaker” to complement or replace traditional implantable devices. The technology uses mRNA-mediated gene transfer – called Tbx18 transduction – to deliver a human gene that dictates the formation of pacemaker tissue. When TBX18 is re-expressed within an adult human, the hallmark features of native